116 related articles for article (PubMed ID: 15733812)
1. The "pain pen" for breakthrough cancer pain: a promising treatment.
Enting RH; Mucchiano C; Oldenmenger WH; Fritzon M; Wallen A; Goslinga-van der Gaag S; Sillevis Smitt PA; Delhaas E
J Pain Symptom Manage; 2005 Feb; 29(2):213-7. PubMed ID: 15733812
[TBL] [Abstract][Full Text] [Related]
2. Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.
Zeppetella G
J Pain Symptom Manage; 2008 May; 35(5):563-7. PubMed ID: 18258412
[TBL] [Abstract][Full Text] [Related]
3. The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen.
Mercadante S; Villari P; Ferrera P; Mangione S; Casuccio A
Clin J Pain; 2010 May; 26(4):306-9. PubMed ID: 20393265
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
5. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
[TBL] [Abstract][Full Text] [Related]
6. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies.
Davies A; Zeppetella G; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M; Buchanan A
Eur J Pain; 2011 Aug; 15(7):756-63. PubMed ID: 21251860
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
10. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
Gordon DB
Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
[TBL] [Abstract][Full Text] [Related]
11. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study.
Hanks GW; Nugent M; Higgs CM; Busch MA;
Palliat Med; 2004 Dec; 18(8):698-704. PubMed ID: 15623166
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
Fisher K; Stiles C; Hagen NA
J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
[TBL] [Abstract][Full Text] [Related]
13. Epidural and intrathecal analgesia is effective in treating refractory cancer pain.
Burton AW; Rajagopal A; Shah HN; Mendoza T; Cleeland C; Hassenbusch SJ; Arens JF
Pain Med; 2004 Sep; 5(3):239-47. PubMed ID: 15367301
[TBL] [Abstract][Full Text] [Related]
14. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
16. Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; Mangione S
J Pain Symptom Manage; 2008 Mar; 35(3):307-13. PubMed ID: 18178368
[TBL] [Abstract][Full Text] [Related]
17. Intranasal sufentanil for cancer-associated breakthrough pain.
Good P; Jackson K; Brumley D; Ashby M
Palliat Med; 2009 Jan; 23(1):54-8. PubMed ID: 19144765
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
20. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
